1. Home
  2. WVE
  3. WVE News

Latest Wave Life Sciences Ltd. (WVE) News on February 22, 2025

What Makes Wave Life Sciences Ltd. (WVE) an Investment Bet?
WVE

Insider Monkey

3 days ago

What Makes Wave Life Sciences Ltd. (WVE) an Investment Bet?

Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity
WVE

GlobeNewswire

16 days ago

Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity

Wave Life Sciences (NASDAQ:WVE) shareholders have earned a 69% CAGR over the last three years
WVE

Simply Wall St.

18 days ago

Wave Life Sciences (NASDAQ:WVE) shareholders have earned a 69% CAGR over the last three years

Is Wave Life Sciences (WVE) the Top Small Cap Stock to Buy with the Highest Upside Potential?
WVE

Insider Monkey

a month ago

Is Wave Life Sciences (WVE) the Top Small Cap Stock to Buy with the Highest Upside Potential?

Wave Life Sciences Highlights Strategic Priorities and Expected 2025 Milestones Ahead of J.P. Morgan Presentation
WVE

GlobeNewswire

a month ago

Wave Life Sciences Highlights Strategic Priorities and Expected 2025 Milestones Ahead of J.P. Morgan Presentation

Is Wave Life Sciences Ltd. (WVE) the Best Growth Stock to Buy Now Under $25?
WVE

Insider Monkey

a month ago

Is Wave Life Sciences Ltd. (WVE) the Best Growth Stock to Buy Now Under $25?

WVE

MT Newswires

2 months ago

Wave Life Sciences Files Clinical Trial Application for WVE-007 To Treat Obesity

Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity
WVE

GlobeNewswire

2 months ago

Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity

Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
WVE

GlobeNewswire

2 months ago

Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

Wave Life Sciences to Present at Upcoming Investor Conferences
WVE

GlobeNewswire

3 months ago

Wave Life Sciences to Present at Upcoming Investor Conferences

Wave Life Sciences to Present at Jefferies London Healthcare Conference
WVE

GlobeNewswire

3 months ago

Wave Life Sciences to Present at Jefferies London Healthcare Conference

Wave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20
WVE

Simply Wall St.

3 months ago

Wave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20

Wave Life Sciences Third Quarter 2024 Earnings: Misses Expectations
WVE

Simply Wall St.

3 months ago

Wave Life Sciences Third Quarter 2024 Earnings: Misses Expectations

WAVE Life Sciences Ltd (WVE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
WVE

GuruFocus.com

3 months ago

WAVE Life Sciences Ltd (WVE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

WVE

MT Newswires

3 months ago

--Truist Securities Adjusts Price Target on Wave Life Sciences to $36 From $17, Keeps Buy Rating

Wave Life Sciences (WVE) Reports Q3 Loss, Lags Revenue Estimates
WVE

Zacks

3 months ago

Wave Life Sciences (WVE) Reports Q3 Loss, Lags Revenue Estimates

WVE

MT Newswires

3 months ago

Wave Life Sciences Swings to Q3 Loss

WVE

Associated Press Finance

3 months ago

Wave Life Sciences: Q3 Earnings Snapshot

Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
WVE

GlobeNewswire

3 months ago

Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update

WAVE Life Sciences Ltd (WVE) Q3 2024: Everything You Need to Know Ahead of Earnings
WVE

GuruFocus.com

3 months ago

WAVE Life Sciences Ltd (WVE) Q3 2024: Everything You Need to Know Ahead of Earnings

Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: Should You Buy?
WVE

Zacks

4 months ago

Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: Should You Buy?

Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024
WVE

GlobeNewswire

4 months ago

Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024

WVE

MT Newswires

4 months ago

B. Riley Adjusts Wave Life Sciences' Price Target to $22 From $19, Maintains Buy Rating

Institutional investors in Wave Life Sciences Ltd. (NASDAQ:WVE) see US$94m decrease in market cap last week, although long-term gains have benefitted them.
WVE

Simply Wall St.

4 months ago

Institutional investors in Wave Life Sciences Ltd. (NASDAQ:WVE) see US$94m decrease in market cap last week, although long-term gains have benefitted them.

Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs
WVE

GlobeNewswire

4 months ago

Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs

How to play biotech stocks: Insmed and Wave Life Sciences
WVE

Yahoo Finance Video

4 months ago

How to play biotech stocks: Insmed and Wave Life Sciences

Wall Street Analysts Predict a 34.53% Upside in Wave Life Sciences (WVE): Here's What You Should Know
WVE

Zacks

4 months ago

Wall Street Analysts Predict a 34.53% Upside in Wave Life Sciences (WVE): Here's What You Should Know

1 Brand-New Big Reason to Buy This Biotech Stock Right Now
WVE

Motley Fool

4 months ago

1 Brand-New Big Reason to Buy This Biotech Stock Right Now

What Makes Wave Life Sciences (WVE) a Strong Momentum Stock: Buy Now?
WVE

Zacks

4 months ago

What Makes Wave Life Sciences (WVE) a Strong Momentum Stock: Buy Now?

Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.
WVE

Investor's Business Daily

4 months ago

Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.

WVE

MT Newswires

4 months ago

RBC Boosts Price Target on Wave Life Sciences to $15 From $7, Keeps Sector Perform, Speculative Risk

Wave Life Sciences Shares Surge After RNA Editing Discovery
WVE

GuruFocus.com

4 months ago

Wave Life Sciences Shares Surge After RNA Editing Discovery

WVE Stock Soars on Upbeat Initial Antitrypsin Deficiency Study Data
WVE

Zacks

4 months ago

WVE Stock Soars on Upbeat Initial Antitrypsin Deficiency Study Data

Wave Life Sciences (WVE) Moves 74.1% Higher: Will This Strength Last?
WVE

Zacks

4 months ago

Wave Life Sciences (WVE) Moves 74.1% Higher: Will This Strength Last?

WVE

MT Newswires

4 months ago

Raymond James Upgrades Wave Life Sciences to Strong Buy From Outperform, Price Target is $22

Wave Life Sciences Just Edited RNA. Why Its Key Rival, Korro Bio, Skyrocketed.
WVE

Investor's Business Daily

4 months ago

Wave Life Sciences Just Edited RNA. Why Its Key Rival, Korro Bio, Skyrocketed.

RNA-Editing Stocks Soar by Record on Wave Life’s Trial Data
WVE

Bloomberg

4 months ago

RNA-Editing Stocks Soar by Record on Wave Life’s Trial Data

WVE

MT Newswires

4 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

WVE

MT Newswires

4 months ago

Sector Update: Health Care

WVE

MT Newswires

4 months ago

Top Midday Gainers

Wave Life Sciences Stock Climbs on RNA Editing Progress
WVE

The Wall Street Journal

4 months ago

Wave Life Sciences Stock Climbs on RNA Editing Progress

WVE

MT Newswires

4 months ago

Update: Wave Life Sciences Shares Soar After Reporting Positive Proof-of-Mechanism Data From WVE-006 Study

WVE

MT Newswires

4 months ago

Wave Life Sciences Reports Positive Proof-of-Mechanism Data From WVE-006 Study; Shares Surge 32% Pre-Bell

GSK Bought More Shares of Biotech Wave Life Sciences
WVE

Barrons.com

4 months ago

GSK Bought More Shares of Biotech Wave Life Sciences

How Much Upside is Left in Wave Life Sciences (WVE)? Wall Street Analysts Think 89.71%
WVE

Zacks

4 months ago

How Much Upside is Left in Wave Life Sciences (WVE)? Wall Street Analysts Think 89.71%

WAVE Life Sciences Ltd (WVE) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Rising ...
WVE

GuruFocus.com

4 months ago

WAVE Life Sciences Ltd (WVE) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Rising ...

WVE

MT Newswires

5 months ago

RBC Raises Price Target on WAVE Life Sciences to $7 From $5, Keeps Sector Perform Rating, Speculative Risk

WVE

MT Newswires

5 months ago

B. Riley Adjusts WAVE Life Sciences' PT to $19 From $11, Maintains Buy Rating

Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics
WVE

Motley Fool

5 months ago

Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics

WVE

MT Newswires

5 months ago

Wave Life Sciences Closes $230 Million Sale of Shares, Warrant

Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
WVE

GlobeNewswire

5 months ago

Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
WVE

GlobeNewswire

5 months ago

Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference

Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More
WVE

Zacks

5 months ago

Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More

WVE

MT Newswires

5 months ago

Wave Life Sciences Prices $200 Million Public Offering

Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
WVE

GlobeNewswire

5 months ago

Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

WVE Stock Soars on Upbeat Efficacy Data From Muscle Disease Study
WVE

Zacks

5 months ago

WVE Stock Soars on Upbeat Efficacy Data From Muscle Disease Study

Wave’s stock swells as it eyes approval following Phase II DMD victory
WVE

Clinical Trials Arena

5 months ago

Wave’s stock swells as it eyes approval following Phase II DMD victory

WVE

MT Newswires

5 months ago

Wave Life Sciences Discloses Planned Offering of Shares, Warrants

WVE

MT Newswires

5 months ago

Sector Update: Health Care Stocks Mixed Late Afternoon

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
WVE

GlobeNewswire

5 months ago

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

WVE

MT Newswires

5 months ago

Sector Update: Health Care Stocks Decline Tuesday Afternoon

WVE

MT Newswires

5 months ago

Top Midday Gainers

WVE

MT Newswires

5 months ago

Wave Life Sciences Shares Soar After 'Positive' Data on Duchenne Muscular Dystrophy Drug Trial

WVE

MT Newswires

5 months ago

HC Wainwright Adjusts Price Target on WAVE Life Sciences to $22 From $15, Maintains Buy Rating

Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug
WVE

Benzinga

5 months ago

Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug

Will Wave Life Sciences (NASDAQ:WVE) Spend Its Cash Wisely?
WVE

Simply Wall St.

5 months ago

Will Wave Life Sciences (NASDAQ:WVE) Spend Its Cash Wisely?

WVE

MT Newswires

5 months ago

Update: B. Riley Initiates WAVE Life Sciences at Buy With $11 Price Target

WVE

MT Newswires

5 months ago

B. Riley Initiates WAVE Life Sciences at Buy

WVE

MT Newswires

5 months ago

JPMorgan Initiates Coverage on WAVE Life Sciences With Overweight Rating, $10 Price Target

Insider Selling: President and CEO Paul Bolno Sells 48,366 Shares of WAVE Life Sciences Ltd (WVE)
WVE

GuruFocus.com

6 months ago

Insider Selling: President and CEO Paul Bolno Sells 48,366 Shares of WAVE Life Sciences Ltd (WVE)

WVE

MT Newswires

6 months ago

Wave Life Sciences' Duchenne MD Treatment Candidate Gets US FDA Rare Pediatric Disease Designation

Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy
WVE

GlobeNewswire

6 months ago

Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy

Wave Life Sciences Ltd. (NASDAQ:WVE) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
WVE

Simply Wall St.

6 months ago

Wave Life Sciences Ltd. (NASDAQ:WVE) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Wave Life Sciences Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
WVE

Simply Wall St.

6 months ago

Wave Life Sciences Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

WVE

MT Newswires

6 months ago

JonesTrading Initiates WAVE Life Sciences at Buy With $12 Price Target

Wave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue Estimates
WVE

Zacks

6 months ago

Wave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue Estimates

WVE

Associated Press Finance

6 months ago

Wave Life Sciences: Q2 Earnings Snapshot

Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update
WVE

GlobeNewswire

6 months ago

Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update

Wave Life Sciences (NASDAQ:WVE investor five-year losses grow to 72% as the stock sheds US$72m this past week
WVE

Simply Wall St.

6 months ago

Wave Life Sciences (NASDAQ:WVE investor five-year losses grow to 72% as the stock sheds US$72m this past week

Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024
WVE

GlobeNewswire

7 months ago

Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024

Analysts Are Betting On Wave Life Sciences Ltd. (NASDAQ:WVE) With A Big Upgrade This Week
WVE

Simply Wall St.

8 months ago

Analysts Are Betting On Wave Life Sciences Ltd. (NASDAQ:WVE) With A Big Upgrade This Week

WVE

MT Newswires

8 months ago

Update: WAVE Life Sciences Discloses 'Positive' Phase 1b/2a Data From Huntington's Disease Treatment But Shares Fall on Neurofilament Concern

WVE

MT Newswires

8 months ago

WAVE Life Sciences Discloses 'Positive' Data From Phase 1b/2a Trial of WVE-003 to Treat Huntington's Disease; Shares Rise Pre-Bell

Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington’s Disease
WVE

GlobeNewswire

8 months ago

Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington’s Disease

Wave, with new data, plots path forward for Huntington’s drug
WVE

BioPharma Dive

8 months ago

Wave, with new data, plots path forward for Huntington’s drug

Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing
WVE

GlobeNewswire

8 months ago

Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing

Bangladesh Ecommerce Market Report 2024, Featuring Daraz Bangladesh, Chaldal, Evaly, Pickaboo and Ajkerdeal - Forecasts to 2028
WVE

GlobeNewswire

8 months ago

Bangladesh Ecommerce Market Report 2024, Featuring Daraz Bangladesh, Chaldal, Evaly, Pickaboo and Ajkerdeal - Forecasts to 2028

3 Major Product Releases at 3Shape Discover Event
WVE

PR Newswire

8 months ago

3 Major Product Releases at 3Shape Discover Event

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens
WVE

GlobeNewswire

8 months ago

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series
WVE

PR Newswire

8 months ago

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029
WVE

GlobeNewswire

8 months ago

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029

EXCLUSIVE: Sunlight Creates Love Note Projections In New Fred Jewelry Collection
WVE

WWD

8 months ago

EXCLUSIVE: Sunlight Creates Love Note Projections In New Fred Jewelry Collection

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights
WVE

GlobeNewswire

8 months ago

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights

Shake Shack (SHAK) Rose after Strong Q4 Results
WVE

Insider Monkey

8 months ago

Shake Shack (SHAK) Rose after Strong Q4 Results

Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference
WVE

GlobeNewswire

9 months ago

Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference

WVE

MT Newswires

9 months ago

Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target

Wave Life Sciences Ltd. (NASDAQ:WVE) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates
WVE

Simply Wall St.

9 months ago

Wave Life Sciences Ltd. (NASDAQ:WVE) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Wave Life Sciences Ltd. (NASDAQ:WVE) Q1 2024 Earnings Call Transcript
WVE

Insider Monkey

9 months ago

Wave Life Sciences Ltd. (NASDAQ:WVE) Q1 2024 Earnings Call Transcript

WVE

GuruFocus.com

9 months ago

WAVE Life Sciences Reports First Quarter 2024 Financial Results

Wave Life Sciences First Quarter 2024 Earnings: US$0.24 loss per share (vs US$0.27 loss in 1Q 2023)
WVE

Simply Wall St.

9 months ago

Wave Life Sciences First Quarter 2024 Earnings: US$0.24 loss per share (vs US$0.27 loss in 1Q 2023)

Share on Social Networks: